Rheumatology News and Research

RSS

Rheumatology is a sub-specialty in internal medicine and pediatrics, devoted to the diagnosis and therapy of rheumatic diseases. Rheumatologists mainly deal with clinical problems involving joints, soft tissues and allied conditions of connective tissues.

Treatment with sildenafil significantly reduces RP in patients with scleroderma

Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud's phenomenon in patients with limited cutaneous systemic sclerosis, also known as scleroderma.

8 Mar 2011

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.

8 Mar 2011

New research may shed light on how HIV virus reactivates from latency

New research enhances the current knowledge of how human immunodeficiency virus type-1, which causes AIDS, controls the cell cycle of cells that it infects. The new findings may shed light on how the virus reactivates after entering a dormant state, called latency.

28 Feb 2011

Takeda receives FDA approval for EDARBI to treat hypertension in adults

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration approved EDARBI for the treatment of hypertension, or high blood pressure, in adults.

27 Feb 2011

ICTS concludes enrollment months ahead of schedule for rheumatology study

ICTS, the patient recruitment and clinical trial services company, has successfully completed the fifth in a series of rheumatology study recruitment efforts for the same sponsor. Using an integrated approach that centered around a study website, social media, geographically initiated keyword search advertising, and also included site enrollment toolkits, the program exceeded the enrollment timelines established by the sponsor.

25 Feb 2011

Savient launches KRYSTEXXA in the U.S.

Savient Pharmaceuticals, Inc. announced the official full U.S. commercial launch of KRYSTEXXA™ (pegloticase), which has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic gout in adult patients refractory to conventional therapy. KRYSTEXXA is now the first and only therapy available to address this unmet medical need.

25 Feb 2011

Takeda submits NDA to FDA for fixed-dose combination of azilsartan medoxomil plus CLD to treat hypertension

Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc. U.S., submitted a New Drug Application to the U.S. Food and Drug Administration for an investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone for the treatment of hypertension, or high blood pressure.

24 Feb 2011

Bunion deformity more frequent in women, greatly reduces general, foot-specific HRQOL

New research determined that an increase in the severity of hallux valgus, or bunion deformity, progressively reduced both general and foot-specific health related quality of life. Bunion deformity was found in 36% of the study population and occurred more frequently in women and older individuals. Pain in other parts of the body beyond the foot was associated with increased bunion severity.

24 Feb 2011

Prevalence of bunions increases with age; More common in women

New research determined that an increase in the severity of hallux valgus, or bunion deformity, progressively reduced both general and foot-specific health related quality of life (HRQOL). Bunion deformity was found in 36% of the study population and occurred more frequently in women and older individuals.

23 Feb 2011

'Experience station' program offers rheumatologists to gain insight into patients' everyday challenges

Pharmaceutical companies are focusing on more unique approaches in the development of educational and experiential solutions for their health care customers at medical conferences, according to Joe Scrocco, chief executive officer of OneWorld, Inc., a leading pharmaceutical consulting firm.

21 Feb 2011

Patients who undergo orthopedic surgeries at high-volume hospitals have better outcomes

Patients who undergo elective orthopedic surgeries at high-volume, regional hospitals have better surgical outcomes and experience fewer complications than those who undergo those surgeries at local hospitals, according to research being presented by Hospital for Special Surgery investigators at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

19 Feb 2011

New study identifies factors that predict dancer ability to return to work after hip arthroscopy

A new study has identified factors that predict the ability of a professional dancer to return to professional performance after hip arthroscopy surgery. The study by Hospital for Special Surgery investigators will be presented at the American Academy of Orthopaedic Surgeons annual meeting, held Feb. 15-19 in San Diego, Calif.

19 Feb 2011

Total knee arthroplasty takes more time to perform in overweight, obese patients

Knee replacement surgery takes far more time to conduct in overweight and obese patients than in normal weight patients, according to recent research at Hospital for Special Surgery in New York.

18 Feb 2011

Platelet-rich fibrin matrix doesn't improve healing after rotator cuff repair

For years, doctors have used platelet rich plasma (PRP) to promote healing in various surgeries, but a recent study demonstrates that a type of PRP did not improve healing after rotator cuff repair.

18 Feb 2011

CMS selects BWH to participate in Medicare Imaging Demonstration project

Brigham and Women's Hospital was selected by the Centers for Medicare & Medicaid Services as one of five conveners of a demonstration project that promotes appropriate utilization of advanced imaging services, CMS announced February 2, 2011.

17 Feb 2011

Spirulina Pacifica supplement may improve immune function, anemia in senior citizens

Cyanotech Corporation, world leader in microalgae-based health and nutrition supplements, announced today that researchers at the University of California at Davis have determined that microalgae-based Hawaiian Spirulina Pacifica may improve immune function and ameliorate anemia in persons over 50.

17 Feb 2011

New computer application automatically detects subtle epileptic brain lesions in MRI scans

Researchers from the Department of Neurology at NYU Langone Medical Center identified potential benefits of a new computer application that automatically detects subtle brain lesions in MRI scans in patients with epilepsy. In a study published in the February 2011 issue of PLoS ONE, the authors discuss the software's potential to assist radiologists in better identifying and locating visually undetectable, operable lesions.

17 Feb 2011

NYU Langone one of 16 centers chosen to participate in American Joint Replacement Registry

The Department of Orthopaedic Surgery at NYU Langone Medical Center has been chosen as one of only 16 centers across the country to participate in the American Joint Replacement Registry (AJRR). The AJRR is a national, independent, not-for-profit organization created to collect key joint replacement and revision data in order to better to monitor device performance and identify underperforming processes while providing information supporting best practices in safety, cost control and advances in technology.

16 Feb 2011

Richard J. Fasenmyer Foundation awards $3M to Cleveland physicians for AIDS research

A three-year, $3 million gift from the Richard J. Fasenmyer Foundation will fund research by a pair of Cleveland physicians into HIV and the body's response in autoimmune diseases.

11 Feb 2011

ACR releases two new provisional definitions of rheumatoid arthritis remission

The American College of Rheumatology today announced the release of two new provisional definitions of rheumatoid arthritis remission, which are to be applied to future RA clinical trials.

4 Feb 2011

Rheumatology News and Research

Further Reading

Treatment with sildenafil significantly reduces RP in patients with scleroderma

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

New research may shed light on how HIV virus reactivates from latency

Takeda receives FDA approval for EDARBI to treat hypertension in adults

ICTS concludes enrollment months ahead of schedule for rheumatology study

Savient launches KRYSTEXXA in the U.S.

Takeda submits NDA to FDA for fixed-dose combination of azilsartan medoxomil plus CLD to treat hypertension

Bunion deformity more frequent in women, greatly reduces general, foot-specific HRQOL

Prevalence of bunions increases with age; More common in women

'Experience station' program offers rheumatologists to gain insight into patients' everyday challenges

Patients who undergo orthopedic surgeries at high-volume hospitals have better outcomes

New study identifies factors that predict dancer ability to return to work after hip arthroscopy

Total knee arthroplasty takes more time to perform in overweight, obese patients

Platelet-rich fibrin matrix doesn't improve healing after rotator cuff repair

CMS selects BWH to participate in Medicare Imaging Demonstration project

Spirulina Pacifica supplement may improve immune function, anemia in senior citizens

New computer application automatically detects subtle epileptic brain lesions in MRI scans

NYU Langone one of 16 centers chosen to participate in American Joint Replacement Registry

Richard J. Fasenmyer Foundation awards $3M to Cleveland physicians for AIDS research

ACR releases two new provisional definitions of rheumatoid arthritis remission

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News